Mankind Pharma Q4 Results: Profit Rises By 62.3 pc To Rs 477 Crore, Revenue Also Up

Alongside this impressive profit growth, Mankind Pharma also witnessed a rise in revenue, which increased by 18.9 percent to Rs 2,441 crore.
Q4 Results, mankind pharma q4 results, mankind pharma q4 results 2024, mankind pharma revenue, mankind pharma net profit

Mankind Pharma Q4 Results: Profit Rises By 62.3 pc To Rs 477 Crore, Revenue Also Up (Image Source: Times Now Digital)

Mankind Pharma, a pharmaceutical company based in Delhi, has reported a significant increase in its net profit for the March quarter of FY24. The company's net profit surged by 62.3 percent to Rs 477 crore, compared to Rs 294 crore recorded last year.

Mankind Pharma Q4 Results 2024: Revenue

Alongside this impressive profit growth, Mankind Pharma also witnessed a rise in revenue, which increased by 18.9 percent to Rs 2,441 crore from Rs 2,052 crore in the previous fiscal year.

Mankind Pharma Q4 Results 2024: EBITDA

At the operational level, the company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) climbed to Rs 591 crore, up from Rs 417 crore in the same period last year.

Mankind Pharma Q4 Results 2024: EBITDA Margin

The EBITDA margin also improved, reaching 24.2 percent compared to 20.3 percent previously.
Sources familiar with the matter revealed to CNBC-TV18 that Mankind Pharma is eyeing the acquisition of Bharat Serum & Vaccines from Private Equity player Advent.

Mankind Pharma: 4th Largest Pharmaceutical Company

Established in 1991, Mankind Pharma holds the position of India’s fourth-largest pharmaceutical company in terms of domestic sales.
Mankind Pharma: Work Area
The company is involved in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations across various therapeutic areas, as well as consumer healthcare products.
Mankind Pharma: Operations
Mankind Pharma operates in both the domestic pharmaceutical business and consumer healthcare business.
Mankind Pharma: Product Portfolio
In the pharmaceutical sector, its product portfolio covers various therapeutic segments including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory medications.
Mankind Pharma's Healthcare Segment
Meanwhile, in the consumer healthcare segment, the company boasts several distinctive brands across categories such as pregnancy detection, antacid powders, vitamin and mineral supplements, oral contraceptives, and anti-acne preparations.
End of Article
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news